The global medical suction devices market size is predicted to worth USD 990.19 million by 2027, growing at a CAGR of 3.7% from 2021 to 2027 owing to increase in the prevalence of respiratory diseases such as COPD, asthma, and other chronic lung diseases all over the world. Additionally, increase in aging population, declining prices of suction devices, increase in the air pollution, increase in the awareness regarding the suction devices, and advanced healthcare systems in developed countries are expected to enhance the sales of the medical suction devices market. A medical suction machine is a device that helps people with breathing problems. As a result of respiratory disorders, mucus and serum are secreted, which must be eliminated from the body. When a patient is unable to release serum or mucus, medical suction devices are utilized to remove it from the body. Suction machines are also utilized for a variety of other purposes, such as during operational procedures and childbirth. One of the factors driving the global market is the inclination for compact and portable devices for medical treatment, as well as the quick phase shift of medical treatment methods from traditional to advanced ways. Furthermore, the ever-increasing prevalence of chronic diseases is propelling the worldwide medical suction devices market forward. One of the major variables fuelling the global market’s expansion is manufacturers’ curious efforts to produce advanced suction devices. Furthermore, the growing number of surgical procedures has aided the market’s expansion. Other factors driving this market expansion include an ageing population, falling suction device prices, rising prevalence of chronic respiratory disorders, and an increase in the number of surgical procedures (which have increased the usage of suction devices that are specifically used during surgeries). Furthermore, emerging markets have provided a plethora of potential for medical suction device manufacturers; however, the highly commoditized industry and limited reimbursement policies may limit the market’s expansion during the projection period.